Alternative splicing immune signature for detecting HBV-related hepatocellular carcinoma in peripheral blood mononuclear cells.
메타분석
1/5 보강
Peripheral blood mononuclear cells (PBMCs) exhibit disease-specific alternative splicing changes that may serve as robust biomarkers for hepatocellular carcinoma (HCC).
- 표본수 (n) 120
- 연구 설계 meta-analysis
APA
Daniels NJ, Hershberger CE, Rotroff DM (2025). Alternative splicing immune signature for detecting HBV-related hepatocellular carcinoma in peripheral blood mononuclear cells.. Biochemistry and biophysics reports, 44, 102306. https://doi.org/10.1016/j.bbrep.2025.102306
MLA
Daniels NJ, et al.. "Alternative splicing immune signature for detecting HBV-related hepatocellular carcinoma in peripheral blood mononuclear cells.." Biochemistry and biophysics reports, vol. 44, 2025, pp. 102306.
PMID
41159202 ↗
Abstract 한글 요약
Peripheral blood mononuclear cells (PBMCs) exhibit disease-specific alternative splicing changes that may serve as robust biomarkers for hepatocellular carcinoma (HCC). Nearly half of the 800,000 annual HCC cases arise from chronic HBV, which affects 254 million people globally, underscoring the urgent need for reliable, non-invasive diagnostic tools. We conducted a comprehensive meta-analysis of PBMC transcriptomes, identifying reproducible immune-related alternative splicing events (ASEs) altered in HBV-related HCC. We identified shifts in inferred immune cell composition and ASEs associated with HBV-related HCC and tumor stage. Using eight immune-related ASEs, we trained a random forest classifier on 120 samples from six independent studies to distinguish HBV-related HCC from chronic HBV, non-HBV liver disease, and healthy controls. The model showed excellent performance in cross-validation (N = 120, AUC: 0.97), internal validation on withheld test samples (N = 54, AUC: 0.99), and external validation with two independent cohorts (N = 27, AUC: 1.00). These findings support PBMC splicing signatures as promising non-invasive biomarkers for early detection and surveillance of HBV-related HCC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- Heat Shock Protein 47 as a Novel Predictive and Diagnostic Biomarker for Thrombosis in Hepatocellular Carcinoma.
- Crosstalk Between -Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.
- Risks, Benefits, and Molecular Targets of Fenugreek Administration in the Treatment of Hepatocellular Carcinoma.
- Machine learning integrating MRI and clinical features predicts early recurrence of hepatocellular carcinoma after resection.